Cargando…

Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction

BACKGROUND: Autologous adipose tissue–derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long‐term effects and the mechanisms involved in allogeneic ATMSCs administr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bobi, Joaquim, Solanes, Núria, Fernández‐Jiménez, Rodrigo, Galán‐Arriola, Carlos, Dantas, Ana Paula, Fernández‐Friera, Leticia, Gálvez‐Montón, Carolina, Rigol‐Monzó, Elisabet, Agüero, Jaume, Ramírez, José, Roqué, Mercè, Bayés‐Genís, Antoni, Sánchez‐González, Javier, García‐Álvarez, Ana, Sabaté, Manel, Roura, Santiago, Ibáñez, Borja, Rigol, Montserrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524109/
https://www.ncbi.nlm.nih.gov/pubmed/28468789
http://dx.doi.org/10.1161/JAHA.117.005771
_version_ 1783252422846578688
author Bobi, Joaquim
Solanes, Núria
Fernández‐Jiménez, Rodrigo
Galán‐Arriola, Carlos
Dantas, Ana Paula
Fernández‐Friera, Leticia
Gálvez‐Montón, Carolina
Rigol‐Monzó, Elisabet
Agüero, Jaume
Ramírez, José
Roqué, Mercè
Bayés‐Genís, Antoni
Sánchez‐González, Javier
García‐Álvarez, Ana
Sabaté, Manel
Roura, Santiago
Ibáñez, Borja
Rigol, Montserrat
author_facet Bobi, Joaquim
Solanes, Núria
Fernández‐Jiménez, Rodrigo
Galán‐Arriola, Carlos
Dantas, Ana Paula
Fernández‐Friera, Leticia
Gálvez‐Montón, Carolina
Rigol‐Monzó, Elisabet
Agüero, Jaume
Ramírez, José
Roqué, Mercè
Bayés‐Genís, Antoni
Sánchez‐González, Javier
García‐Álvarez, Ana
Sabaté, Manel
Roura, Santiago
Ibáñez, Borja
Rigol, Montserrat
author_sort Bobi, Joaquim
collection PubMed
description BACKGROUND: Autologous adipose tissue–derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long‐term effects and the mechanisms involved in allogeneic ATMSCs administration on myocardial performance. METHODS AND RESULTS: Thirty‐eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic ATMSCs or culture medium (vehicle) were intracoronarily administered. Follow‐ups were performed at short (2 days after acute myocardial infarction vehicle‐treated, n=10; ATMSCs‐treated, n=9) or long term (60 days after acute myocardial infarction vehicle‐treated, n=7; ATMSCs‐treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the ATMSCs‐treated animals (48.6±6% versus 55.9±5.7% in vehicle; P=0.017); enhancement of the reparative process with up‐regulated vascular endothelial growth factor, granulocyte macrophage colony‐stimulating factor, and stromal‐derived factor‐1α gene expression; and increased M2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; P=0.016). In long‐term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day‐7 and day‐60 cardiac magnetic resonance studies in ATMSCs‐treated animals, compared to vehicle (87.9±28.7 versus 57.4±17.7 mL/min per gram at 7 days; P=0.034 and 99±22.6 versus 43.3±14.7 22.6 mL/min per gram at 60 days; P=0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the ATMSCs‐treated animals (118±18 versus 92.4±24.3 vessels/mm(2) in vehicle; P=0.045). Cardiac magnetic resonance–measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. CONCLUSIONS: In this porcine acute myocardial infarction model, allogeneic ATMSCs‐based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance–measured perfusion. No effect on left ventricular volumes or ejection fraction was observed.
format Online
Article
Text
id pubmed-5524109
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-55241092017-08-02 Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction Bobi, Joaquim Solanes, Núria Fernández‐Jiménez, Rodrigo Galán‐Arriola, Carlos Dantas, Ana Paula Fernández‐Friera, Leticia Gálvez‐Montón, Carolina Rigol‐Monzó, Elisabet Agüero, Jaume Ramírez, José Roqué, Mercè Bayés‐Genís, Antoni Sánchez‐González, Javier García‐Álvarez, Ana Sabaté, Manel Roura, Santiago Ibáñez, Borja Rigol, Montserrat J Am Heart Assoc Original Research BACKGROUND: Autologous adipose tissue–derived mesenchymal stem cells (ATMSCs) therapy is a promising strategy to improve post–myocardial infarction outcomes. In a porcine model of acute myocardial infarction, we studied the long‐term effects and the mechanisms involved in allogeneic ATMSCs administration on myocardial performance. METHODS AND RESULTS: Thirty‐eight pigs underwent 50 minutes of coronary occlusion; the study was completed in 33 pigs. After reperfusion, allogeneic ATMSCs or culture medium (vehicle) were intracoronarily administered. Follow‐ups were performed at short (2 days after acute myocardial infarction vehicle‐treated, n=10; ATMSCs‐treated, n=9) or long term (60 days after acute myocardial infarction vehicle‐treated, n=7; ATMSCs‐treated, n=7). At short term, infarcted myocardium analysis showed reduced apoptosis in the ATMSCs‐treated animals (48.6±6% versus 55.9±5.7% in vehicle; P=0.017); enhancement of the reparative process with up‐regulated vascular endothelial growth factor, granulocyte macrophage colony‐stimulating factor, and stromal‐derived factor‐1α gene expression; and increased M2 macrophages (67.2±10% versus 54.7±10.2% in vehicle; P=0.016). In long‐term groups, increase in myocardial perfusion at the anterior infarct border was observed both on day‐7 and day‐60 cardiac magnetic resonance studies in ATMSCs‐treated animals, compared to vehicle (87.9±28.7 versus 57.4±17.7 mL/min per gram at 7 days; P=0.034 and 99±22.6 versus 43.3±14.7 22.6 mL/min per gram at 60 days; P=0.0001, respectively). At day 60, higher vascular density was detected at the border zone in the ATMSCs‐treated animals (118±18 versus 92.4±24.3 vessels/mm(2) in vehicle; P=0.045). Cardiac magnetic resonance–measured left ventricular ejection fraction of left ventricular volumes was not different between groups at any time point. CONCLUSIONS: In this porcine acute myocardial infarction model, allogeneic ATMSCs‐based therapy was associated with increased cardioprotective and reparative mechanisms and with better cardiac magnetic resonance–measured perfusion. No effect on left ventricular volumes or ejection fraction was observed. John Wiley and Sons Inc. 2017-05-03 /pmc/articles/PMC5524109/ /pubmed/28468789 http://dx.doi.org/10.1161/JAHA.117.005771 Text en © 2017 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Bobi, Joaquim
Solanes, Núria
Fernández‐Jiménez, Rodrigo
Galán‐Arriola, Carlos
Dantas, Ana Paula
Fernández‐Friera, Leticia
Gálvez‐Montón, Carolina
Rigol‐Monzó, Elisabet
Agüero, Jaume
Ramírez, José
Roqué, Mercè
Bayés‐Genís, Antoni
Sánchez‐González, Javier
García‐Álvarez, Ana
Sabaté, Manel
Roura, Santiago
Ibáñez, Borja
Rigol, Montserrat
Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
title Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
title_full Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
title_fullStr Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
title_full_unstemmed Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
title_short Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
title_sort intracoronary administration of allogeneic adipose tissue–derived mesenchymal stem cells improves myocardial perfusion but not left ventricle function, in a translational model of acute myocardial infarction
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524109/
https://www.ncbi.nlm.nih.gov/pubmed/28468789
http://dx.doi.org/10.1161/JAHA.117.005771
work_keys_str_mv AT bobijoaquim intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT solanesnuria intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT fernandezjimenezrodrigo intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT galanarriolacarlos intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT dantasanapaula intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT fernandezfrieraleticia intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT galvezmontoncarolina intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT rigolmonzoelisabet intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT aguerojaume intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT ramirezjose intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT roquemerce intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT bayesgenisantoni intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT sanchezgonzalezjavier intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT garciaalvarezana intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT sabatemanel intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT rourasantiago intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT ibanezborja intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction
AT rigolmontserrat intracoronaryadministrationofallogeneicadiposetissuederivedmesenchymalstemcellsimprovesmyocardialperfusionbutnotleftventriclefunctioninatranslationalmodelofacutemyocardialinfarction